Northwest Investment Counselors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $208K | Buy |
+1,051
| New | +$196K | 0.05% | 148 |
|
|
2024
Q2 | – | Sell |
-1,031
| Closed | -$188K | – | 146 |
|
|
2024
Q1 | $188K | Buy |
+1,031
| New | +$178K | 0.05% | 143 |
|
|
2023
Q4 | – | Sell |
-1,864
| Closed | -$278K | – | 139 |
|
|
2023
Q3 | $278K | Buy |
1,864
+679
| +57% | +$99.7K | 0.08% | 131 |
|
|
2023
Q2 | $160K | Sell |
1,185
-137
| -10% | -$20.1K | 0.04% | 158 |
|
|
2023
Q1 | $211K | Sell |
1,322
-1,180
| -47% | -$180K | 0.06% | 150 |
|
|
2022
Q4 | $404K | Sell |
2,502
-4,087
| -62% | -$627K | 0.12% | 122 |
|
|
2022
Q3 | $884K | Sell |
6,589
-363
| -5% | -$52.1K | 0.29% | 86 |
|
|
2022
Q2 | $1.06M | Hold |
6,952
| – | – | 0.33% | 82 |
|
|
2022
Q1 | $1.13M | Sell |
6,952
-915
| -12% | -$133K | 0.3% | 83 |
|
|
2021
Q4 | $1.06M | Sell |
7,867
-1,300
| -14% | -$154K | 0.26% | 83 |
|
|
2021
Q3 | $989K | Buy |
9,167
+860
| +10% | +$98.3K | 0.28% | 82 |
|
|
2021
Q2 | $936K | Buy |
8,307
+152
| +2% | +$17.1K | 0.26% | 86 |
|
|
2021
Q1 | $883K | Hold |
8,155
| – | – | 0.25% | 84 |
|
|
2020
Q4 | $874K | Buy |
8,155
+156
| +2% | +$15K | 0.27% | 85 |
|
|
2020
Q3 | $701K | Hold |
7,999
| – | – | 0.24% | 85 |
|
|
2020
Q2 | $785K | Buy |
7,999
+141
| +2% | +$12.4K | 0.3% | 78 |
|
|
2020
Q1 | $599K | Sell |
7,858
-300
| -4% | -$25.6K | 0.27% | 87 |
|
|
2019
Q4 | $722K | Hold |
8,158
| – | – | 0.25% | 95 |
|
|
2019
Q3 | $618K | Sell |
8,158
-175
| -2% | -$12K | 0.22% | 105 |
|
|
2019
Q2 | $606K | Sell |
8,333
-74
| -0.9% | -$5.82K | 0.22% | 104 |
|
|
2019
Q1 | $678K | Buy |
8,407
+123
| +1% | +$10.1K | 0.26% | 95 |
|
|
2018
Q4 | $764K | Buy |
8,284
+41
| +0.5% | +$3.61K | 0.33% | 82 |
|
|
2018
Q3 | $780K | Buy |
8,243
+230
| +3% | +$21.8K | 0.3% | 87 |
|
|
2018
Q2 | $742K | Sell |
8,013
-108
| -1% | -$10.5K | 0.3% | 87 |
|
|
2018
Q1 | $769K | Sell |
8,121
-357
| -4% | -$39.2K | 0.32% | 83 |
|
|
2017
Q4 | $820K | Buy |
8,478
+4
| +0% | +$377 | 0.33% | 85 |
|
|
2017
Q3 | $753K | Hold |
8,474
| – | – | 0.33% | 84 |
|
|
2017
Q2 | $614K | Hold |
8,474
| – | – | 0.28% | 88 |
|
|
2017
Q1 | $552K | Sell |
8,474
-1,387
| -14% | -$87.2K | 0.27% | 94 |
|
|
2016
Q4 | $617K | Sell |
9,861
-356
| -3% | -$21.7K | 0.31% | 86 |
|
|
2016
Q3 | $644K | Buy |
10,217
+130
| +1% | +$8.42K | 0.33% | 84 |
|
|
2016
Q2 | $624K | Sell |
10,087
-727
| -7% | -$44.3K | 0.34% | 83 |
|
|
2016
Q1 | $618K | Buy |
10,814
+1,322
| +14% | +$73.7K | 0.35% | 81 |
|
|
2015
Q4 | $562K | Sell |
9,492
-476
| -5% | -$27.4K | 0.35% | 82 |
|
|
2015
Q3 | $542K | Sell |
9,968
-250
| -2% | -$16.3K | 0.36% | 82 |
|
|
2015
Q2 | $687K | Hold |
10,218
| – | – | 0.42% | 72 |
|
|
2015
Q1 | $598K | Sell |
10,218
-200
| -2% | -$12.1K | 0.37% | 75 |
|
|
2014
Q4 | $682K | Sell |
10,418
-1,322
| -11% | -$83.3K | 0.44% | 71 |
|
|
2014
Q3 | $678K | Sell |
11,740
-2,690
| -19% | -$149K | 0.46% | 68 |
|
|
2014
Q2 | $814K | Sell |
14,430
-1,300
| -8% | -$68.2K | 0.55% | 64 |
|
|
2014
Q1 | $809K | Sell |
15,730
-1,248
| -7% | -$63.1K | 0.56% | 62 |
|
|
2013
Q4 | $897K | Sell |
16,978
-1,190
| -7% | -$58.5K | 0.62% | 62 |
|
|
2013
Q3 | $813K | Sell |
18,168
-1,109
| -6% | -$49.2K | 0.62% | 60 |
|
|
2013
Q2 | $797K | Buy |
+19,277
| New | +$843K | 0.67% | 60 |
|
Other funds holding ABBV
Northwest Investment Counselors's ABBV Position: Q3 2024 in Review
Northwest Investment Counselors opened a new position in AbbVie (ABBV) in Q3 2024: 1,051 shares worth $208K. The stake represents 0.05% of the portfolio and ranks #148 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in ABBV as recently as Q1 2024.
Northwest Investment Counselors first reported a position in ABBV in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.13M in Q1 2022. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- Northwest Investment Counselors held 1,051 shares of AbbVie worth $208K as of Q3 2024.
- AbbVie was a new Northwest Investment Counselors position in Q3 2024.
- AbbVie made up 0.05% of Northwest Investment Counselors's portfolio in Q3 2024, its #148 holding.
- Northwest Investment Counselors first reported a position in AbbVie in Q2 2013 and has held it in 44 quarters since.
- Northwest Investment Counselors's AbbVie position peaked at $1.13M in Q1 2022.
- 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.